These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 28298257)

  • 21. The value of liver magnetic resonance imaging in patients with findings of resectable pancreatic cancer on computed tomography.
    Chew C; O'Dwyer PJ
    Singapore Med J; 2016 Jun; 57(6):334-8. PubMed ID: 27353741
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Preoperative detection of colorectal liver metastases: DWI alone or combined with MDCT is no substitute for Gd-EOB-DTPA-enhanced MRI.
    Schulz A; Joelsen-Hatlehol ES; Brudvik KW; Aasand KK; Hanekamp B; Viktil E; Johansen CK; Dormagen JB
    Acta Radiol; 2020 Mar; 61(3):302-311. PubMed ID: 31335157
    [No Abstract]   [Full Text] [Related]  

  • 23. Health economic evaluation of Gd-EOB-DTPA MRI vs ECCM-MRI and multi-detector computed tomography in patients with suspected hepatocellular carcinoma in Thailand and South Korea.
    Lee JM; Kim MJ; Phongkitkarun S; Sobhonslidsuk A; Holtorf AP; Rinde H; Bergmann K
    J Med Econ; 2016 Aug; 19(8):759-68. PubMed ID: 27026278
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of gadoxetic acid-enhanced magnetic resonance imaging in the preoperative evaluation of small hepatic lesions in patients with colorectal cancer.
    Cho JY; Lee YJ; Han HS; Yoon YS; Kim J; Choi Y; Shin HK; Lee W
    World J Surg; 2015 May; 39(5):1161-6. PubMed ID: 25609116
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Colorectal Cancer Liver Metastases: Diagnostic Performance and Prognostic Value of PET/MR Imaging.
    Lee DH; Lee JM; Hur BY; Joo I; Yi NJ; Suh KS; Kang KW; Han JK
    Radiology; 2016 Sep; 280(3):782-92. PubMed ID: 27092659
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Liver tumors: comparison of MR imaging with Gd-EOB-DTPA and Gd-DTPA.
    Vogl TJ; Kümmel S; Hammerstingl R; Schellenbeck M; Schumacher G; Balzer T; Schwarz W; Müller PK; Bechstein WO; Mack MG; Söllner O; Felix R
    Radiology; 1996 Jul; 200(1):59-67. PubMed ID: 8657946
    [TBL] [Abstract][Full Text] [Related]  

  • 27. One-stop-shop preoperative evaluation for living liver donors with gadoxetic acid disodium-enhanced magnetic resonance imaging: efficiency and additional benefit.
    Xie S; Liu C; Yu Z; Ren T; Hou J; Chen L; Huang L; Cheng Y; Ji Q; Yin J; Zhang L; Shen W
    Clin Transplant; 2015 Dec; 29(12):1164-72. PubMed ID: 26448564
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy and safety of MR imaging with liver-specific contrast agent: U.S. multicenter phase III study.
    Bluemke DA; Sahani D; Amendola M; Balzer T; Breuer J; Brown JJ; Casalino DD; Davis PL; Francis IR; Krinsky G; Lee FT; Lu D; Paulson EK; Schwartz LH; Siegelman ES; Small WC; Weber TM; Welber A; Shamsi K
    Radiology; 2005 Oct; 237(1):89-98. PubMed ID: 16126918
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gd-EOB-DTPA-enhanced magnetic resonance imaging for bile duct intraductal papillary mucinous neoplasms.
    Ying SH; Teng XD; Wang ZM; Wang QD; Zhao YL; Chen F; Xiao WB
    World J Gastroenterol; 2015 Jul; 21(25):7824-33. PubMed ID: 26167082
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Incremental value of liver MR imaging in patients with potentially curable colorectal hepatic metastasis detected at CT: a prospective comparison of diffusion-weighted imaging, gadoxetic acid-enhanced MR imaging, and a combination of both MR techniques.
    Kim HJ; Lee SS; Byun JH; Kim JC; Yu CS; Park SH; Kim AY; Ha HK
    Radiology; 2015 Mar; 274(3):712-22. PubMed ID: 25286324
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Detection of colo-rectal liver metastases: prospective comparison of contrast enhanced US, multidetector CT, PET/CT, and 1.5 Tesla MR with extracellular and reticulo-endothelial cell specific contrast agents.
    Mainenti PP; Mancini M; Mainolfi C; Camera L; Maurea S; Manchia A; Tanga M; Persico F; Addeo P; D'Antonio D; Speranza A; Bucci L; Persico G; Pace L; Salvatore M
    Abdom Imaging; 2010 Oct; 35(5):511-21. PubMed ID: 19562412
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Detection of pancreatic ductal adenocarcinoma and liver metastases: comparison of Gd-EOB-DTPA-enhanced MR imaging vs. extracellular contrast materials.
    Noda Y; Goshima S; Takai Y; Kawai N; Kawada H; Tanahashi Y; Matsuo M
    Abdom Radiol (NY); 2020 Aug; 45(8):2459-2468. PubMed ID: 32248260
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of gadoxetic acid-enhanced dynamic imaging and diffusion-weighted imaging for the preoperative evaluation of colorectal liver metastases.
    Chung WS; Kim MJ; Chung YE; Kim YE; Park MS; Choi JY; Kim KW
    J Magn Reson Imaging; 2011 Aug; 34(2):345-53. PubMed ID: 21702068
    [TBL] [Abstract][Full Text] [Related]  

  • 34. "Nondefect" of arterial enhancing rim on hepatobiliary phase in 3.0-T gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid-enhanced liver magnetic resonance imaging: distinguishing hepatic abscess from metastasis.
    Choi SH; Lee CH; Kim BH; Lee J; Choi JW; Park YS; Kim KA; Park CM
    J Comput Assist Tomogr; 2013; 37(6):849-55. PubMed ID: 24270105
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intraindividual comparison of gadoxetate disodium-enhanced MR imaging and 64-section multidetector CT in the Detection of hepatocellular carcinoma in patients with cirrhosis.
    Di Martino M; Marin D; Guerrisi A; Baski M; Galati F; Rossi M; Brozzetti S; Masciangelo R; Passariello R; Catalano C
    Radiology; 2010 Sep; 256(3):806-16. PubMed ID: 20720069
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Peripheral low intensity sign in hepatic hemangioma: diagnostic pitfall in hepatobiliary phase of Gd-EOB-DTPA-enhanced MRI of the liver.
    Tamada T; Ito K; Ueki A; Kanki A; Higaki A; Higashi H; Yamamoto A
    J Magn Reson Imaging; 2012 Apr; 35(4):852-8. PubMed ID: 22127980
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gadobenate dimeglumine-enhanced 3.0-T MR imaging versus multiphasic 64-detector row CT: prospective evaluation in patients suspected of having pancreatic cancer.
    Koelblinger C; Ba-Ssalamah A; Goetzinger P; Puchner S; Weber M; Sahora K; Scharitzer M; Plank C; Schima W
    Radiology; 2011 Jun; 259(3):757-66. PubMed ID: 21436084
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Contrast-enhanced computed tomography plus gadolinium-ethoxybenzyl diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging for gross classification of hepatocellular carcinoma.
    Chen C; Zhao H; Fu X; Huang L; Tang M; Yan X; Sun S; Jia W; Mao L; Shi J; Chen J; He J; Zhu J; Qiu Y
    Oncotarget; 2017 May; 8(18):29741-29750. PubMed ID: 28392502
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adjunctive role of preoperative liver magnetic resonance imaging for potentially resectable pancreatic cancer.
    Kim HW; Lee JC; Paik KH; Kang J; Kim YH; Yoon YS; Han HS; Kim J; Hwang JH
    Surgery; 2017 Jun; 161(6):1579-1587. PubMed ID: 28237643
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Preoperative detection of colorectal liver metastases in fatty liver: MDCT or MRI?
    Kulemann V; Schima W; Tamandl D; Kaczirek K; Gruenberger T; Wrba F; Weber M; Ba-Ssalamah A
    Eur J Radiol; 2011 Aug; 79(2):e1-6. PubMed ID: 20392584
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.